Abstract:OBJECTIVE:To assess the efficacy and pathological change of fertility-sparing treatment with progestin for endometrial carcinoma (EC) of stage I a and complex atypical hyperplasia (CAH) and to observe the prognosis of the treatment.METHODS:Nine EC patients of stage I a and 21 CAH patients aged under 40 years who desired childbearing and retaining their fertility were enrolled into this study. All patients were given a daily oral high-dose of progestin with duration of treatment ranging from 6 to 9 months. Diagnostic curettage was performed every 3 months as a modality for seeing the histologic change of neoplastic tissues and endometrial tissue. A careful and long- term follow- up is necessary for patients with complete response (CR).RESULTS:During the first period of fertility-sparing management, according to histologic change, 5 EC patients and 18 CAH patients showed CR with no evidence of endometrial adenocarcinoma or hyperplasia, 2 EC patients and 2 CAH patients showed partial response with a regression to complex or simple hyperplasia without atypia, 2 EC patients and 1 CAH patient showed stable disease or progressive disease. Accordingly, a total of 26 patients showed CR (26 of 30 patients). The median time to CR was 6 months (range, 3 to 21 months) of progestin treatment. The median follow-up time was 55.5 months (range, 24 to 104 months) and all patients were alive. During follow-up, among the 26 patients with CR, 3 of 6 EC patients achieved CR recurred disease after a median time interval of 10 months (range, 6 to 51 months), 7 of 20 CAH patients achieved CR had recurrent disease after a median time interval of 12 months (range, 6 to 55 months). Four of 7 CAH with recurrent disease achieved CR to progestin re-treatment. Eight of 26 patients achieved CR continued a further 3 or 6 months of consolidation therapy, 3 of them had recurrent disease, the remaining 18 stopped progesterone treatment after CR and 7 patients had recurrent disease; there was no significant statistical difference between the two groups (P = 1.000). EC patients succeeded in 4 pregnancies, CAH patients succeeded in 10 pregnancies, they gave birth to 16 healthy babies in all.CONCLUSIONS:EC of stage I a and CAH had slow progression of symptoms. Progestin treatment in EC of stage I a and CAH patients was effective. A careful and long-term follow-up is required because of the substantial high rate of recurrence. Progestin re-treatment in most patients with recurrent endometrial cancer is effective and safe.

Analysis of the clinical characteristics of 309 patients with endometrial carcinoma during the perioperative period

[A Clinical Analysis of 146 Cases of Endometrial Carcinoma with Medical Disorders].

A Clinicopathologic and Prognostic Analysis of 115 Cases of Endometrial Carcinoma

Primary Clinical Analysis of Medical Disorders in Chinese Women with Endometrial Carcinoma

Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma

Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma.

[Analysis of the Risk Factors for Ovarian Metastasis in Patients with Endometrial Carcinoma].

Accuracy of Tumor Grade by Preoperative Curettage and Associated Clinicopathologic Factors in Clinical Stage I Endometriod Adenocarcinoma

Management of endometrioid carcinomapatients with preoperative diagnosis of endometrial hyperplasia

The significance of pelvic lymphadenectomy for stage I endometrial carcinoma.

[Accuracy of Preoperative Tumor Grading and Intraoperative Gross Examination of Myometrial Invasion in Clinical Stage I Endometriod Adenocarcinoma].

[Effects of Pathological Assessment of Endometrial Tissue in Fertility-Sparing Treatment with Progestin for Endometrial Carcinoma of Stage I a and Complex Atypical Hyperplasia].

Investigation on risk factors of endometrial carcinomas and atypical endometrial hyperplasia

Influence of Neoadjuvant Chemotherapy on VEGF Mrna Expression in Endometrial Carcinoma

Analysis on Pre-Operative and Intra-Operative Diagnosis Accuracy of the Patients with High-Risk Endometrial Carcinoma

A Clinical Analysis on the Prognosis and Its Related Factors of Advanced Endometrial Carcinoma

Clinical analysis of treatment outcome for 435 patients with endometrial cancer

Clinical Analysis of 85 Cases of Endometrial Carcinoma

[Impact of Surgical Resection Extent on the Prognosis of Clinical Stage I Endometrial Carcinoma].

The Relationship between Menopausal State and Prognosis of Endometrial Cancer

Association between metabolic disorders and clinicopathologic features in endometrial cancer